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Oesophageal papillonias were induced in male F344 rats by
continuous exposure to A'-nitrosomethylbenzylamine
(NMBzA) and Af-nitrosomethyl(2-methylbutyl)amine in the
drinking water at concentrations of 10 and 19.5 p.p.m.
respectively. After 81 -141 days animak received a single i.p.
chasing dose of NMBzA (0.1 mmol/kg), [14C-methji]NMBzA
or Ar-nhroso[14C-methyl]amylamine and were killed 6 h
later. Induced papillomas (3—9 per animal) were analysed
by autoradiography and by immunohistochemistry using a
polyclonal antibody to <96-methyldeoxyguanosine. Both
techniques revealed the presence of high levels of alkylation
products in all papiOomas investigated. Immunohistechemical
staining of C^-methyldeoxyguanosine was largely restricted
to nuclei of the basal layer and of epithelial cells with incipient
keratinization. These findings demonstrate that NMBzA and
JV-nitrosomethylamylamine and probably related methyl-
alkylnitrosamines are effectively bioacti vated in premalignant
lesions, indicating that during chronic exposure papillomas
can acquire additional mutations that are likely to play a
major role in tumour progression.
Introduction
N-Nitrosomethylbenzylamine (NMBzA*), A'-nitrosomethyl-
amylamine (NMAA) and related asymmetric Af-nitrosodialkyl-
amines selectively induce tumours of the rat oesophagus, largely
irrespective of the mode of administration (1). There is evidence
that this organ specificity is due to the presence of cytochrome
P450 isozymes in rat oesophagus which efficiently bioactivate
this group of carcinogens by a-C hydroxylation at either the
methyl group or at the opposite aliphatic or aromatic moiety
(2 -4 ) . Biochemical studies have revealed that the latter pathway,
which leads to the formation of a methylating intermediate,
predominates and that methylated DNA bases are likely to be
responsible for tumour initiation by this group of carcinogens
(5—7). Immunohistochemical studies using antibodies specific
for the promutagenic DNA-base C^-methyldeoxyguanosine have
shown that bioactivation occurs in the mucosa proper, with
alkylated nucleic detectable predominantly in the basal cell layer
(8-10).
Histological analyses have revealed that NMBzA and related
asymmetric methylalkyhiitrosamines typically induce papillomas
as early benign precursor lesions. Some of these papillomas
ultimately progress to form squamous carcinomas. In the present
study, we have investigated whether and to what extent
•Abbreviations: NMBzA, A/-nitrosomethylbenzylamine; NMAA, A'-nitroso-
methylamylamine; NM2MBA, A'-nitrosomethyl(2-methylbutyl)amine; BUdR,
5-bromodeoxyuridine
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papillomas maintain the capacity to bioactive the nitrosamines
responsible for their induction. Using autoradiographic and
immunohistochemical techniques, it could clearly be shown that
all papillomas investigated bioactivate NMBzA and related agents,
indicating that during continuous exposure additional mutations
can be induced in these premalignant lesions.
Materials and methods
Chemicals and antibodies
[l4C-methyl]NMBzA was synthesized according to Skipper (11). The
radiochemical purity was >95%. [l4C-methyl]NMAA was prepared as described
previously (9). Af-nitrosomethyl(2-methylbutyl)amine (NM2MBA) was from the
German Cancer Research Centre, Heidelberg, FRG. RNase T, from Aspergillus
oryzae was from Boehringer-Mannheim AG, Rotkreuz, Switzerland. Disulfiram,
RNase A from bovine pancreas, ovalbumin and 3,3-diaminobenzidine-4HCl were
purchased from Sigma Chemie, Deisenhofen, FRG. Peroxidase-(rabbit)anti-
peroxidase complex, swine anti-rabbit Ig (raised against rabbit serum pool),
biotinylated rabbit anti-mouse Ig, non-immune swine and rabbit sera and
avidin—biotin peroxidase complex were obtained from Dakopatts AS, Glostrup,
Denmark. Monoclonal anti-BUdR antibody was from Becton-Dickinson, Basel,
Switzerland. Characteristics of the rabbit antiserum raised against keyhole limpet
haemocyanin conjugates of C^-methylguanosine (NPZ 193-1) have been
described earlier (12). The antiserum was used without prior absorption. All other
chemicals were of analytical grade OT higher.
Tumour induction
Male Fischer 344 rats with an average weight of 104 g were obtained from Charles
River Wiga, Sulzfeld, FRG. The animals were maintained on water ad libitum
to which NMBzA or NM2MBA was added as indicated in Table I. Rats exposed
to NMBzA were given a semi-synthetic rat chow (no. 2040; KlingentalrnOhle,
Kaiseraugst, Switzerland) to which disulfiram was added at a final concentration
of 200 mg/kg: 1 kg of the pulverized pellets and 200 mg disulfiram were mixed
with 600 ml of water, formed into pellets (30-50 g) and air dried for 3 days.
Disulfiram decreases the metabolism of NMBzA in rat liver, leading to extended
exposure to the carcinogen and thus to higher levels of DNA methylation in
extrahepatic tissues. This metabolic shift is associated with a marked accelera-
tion of oesophageal tumorigenesis (13,14).
Chasing dose
A single chasing dose of NMBzA [ uC-methyl]NMBzA or [l4C-methyl]NMAA
was administered by i.p. injection as indicated in Table I. After 6 h (NMBzA)
or 2 h ([l4C-methyl]NMBzA, [14C-methyl]NMAA), the animals were killed by
exsanguination during ether anaesthesia.
Autoradiography
For autoradiographic studies, rats were pretreated with an i.p. injection of
hydroxyurea (500 mg/kg) followed 30 min later by an i.p. dose of the labelled
nitrosamine (Table I). Tissues were fixed in buffer formaldehyde (4%, v/v),
embedded in paraffin, and cut into 4 pm sections. Exposure of contact
autoradiographs (LKB 3H-Ultrofilm) was carried out for 3 weeks in an X-ray
cassette. Films were processed with Kodak D19 developer and Kodak Unifix
fixation salt.
Immunohistochemistry for O^-methyldeoxyguanosine
The organs were removed rapidly and quickly frozen onto small aluminum plates
placed directly on slabs of dry ice. Cryostat sections (6—10 /un) were mounted
on ovalbumin-coated slides. Immunohistochemical staining was carried out
essentially according to Scherer et al. (15) as detailed earlier (9). Endogenous
peroxidase was inactivated by a 45 min incubation with 0.3% H J O J in methanol.
After rehydration via graded ethanol, sections were equilibrated with 10 mM
EDTA in 10 mM EDTA in 10 mM Tris, pH 8.0, for 5 min and subsequently
treated for 60 min at 37°C with RNase A (200 /jg/ml) and RNase T, (50 U/ml)
in the same buffer. The sections were then rinsed with distilled water, equilibrated
in 40% ethanol for 1 min and treated for 10 min at room temperature with 50 mM
NaOH in 40% ethanol to denature the DNA, quickly neutralized with 5% glacial
acetic acid in 40% ethanol, washed once with water, incubated for 5 min in wash
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buffer (50 mM TrU, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.25% gelatine,
0.05% Triton X-100), and then washed in PBS (123 mM NaCl, 8.3 mM
Na^HPO,,, 3.2 mM KH2PO4, pH 7.4). The sections were subsequently
preincubated (60 min, 37°C) with antibody dilution buffer (10% heat-inactivated
non-immune swine serum in PBS containing 0.04% Triton X-100). The reaction
with the anti-O'-methyldeoxyguanosine serum (diluted 1:10 000) was carried out
for 16 h at 4°C. After this and all of the following incubation steps the sections
were rinsed once with PBS, once with wash buffer and again with PBS. Bound
antibodies were visualized by the 'double PAP' staining procedure, which involved
successive incubations with swine anti-rabbit Ig, peroxidase-(rabbit)antiperoxidase
complex, swine anti-rabbit Ig, and peroxidase-(rabbit)antiperoxidase complex,
each for 45 min at room temperature. Enzymatic activity was revealed by
incubation in 50 mM Tris-HCl, pH 7.4, 3,3-diaminobenzidine-4HCl
(0.5 mg/ml) and 0.015% H2C>2 for 5-10 min at room temperature. The sections
were washed with distilled water, lightly counterstained with H&E, dehydrated
and mounted.
Bromodeoxyuridine (BUdR) immunohistochemistry
BUdR was given as a single i.p. dose (20 mg/kg body wt). Two hours later,
animals were killed and tissues were fixed in 70% (v/v) ethanol overnight,
dehydrated and embedded in paraffin. Slides were deparaffinized and stained with
a monoclonal antibody to BUdR, followed by incubations with biotinylated rabbit-
anti-mouse Ig antibodies, avidin-biotin horseradish peroxklase and 3,3-diamino-
benzidine —4HC1 (16,17). Sections were counterstained with haematoxylin.
Results and Discussion
The aim of the present study was to determine whether early
neoplastic lesions in the rat oesophagus retain the ability to
bioactivate asymmetric methylalkylnitrosamines. Two methods
of investigation were used. After administration of l4C-labelled
carcinogens, autoradiography with dehydrated, paraffin-
embedded sections was used to visualize 14C radioactivity bound
to cellular macromolecules, including DNA, RNA and proteins.
In order to reduce metabolic incorporation of the label via the
Cl-pool, which may occur to a significant extent in tissues with
a high cell turnover, the survival time was kept short (2 h) and
animals were pretreated with a single i.p. dose of hydroxyurea
(500 mg/kg) which causes almost complete inhibition of DNA
synthesis for 3 h (18). We have previously shown that in rat
duodenum, i.e. a tissue notorious for high metabolic incorpora-
tion, treatment with hydroxyurea reduces purine labelling by
>98% (9). The autoradiography shown in Figure 1, prepared
after a chasing dose of [ C-methyl]NMBzA, clearly demon-
strates that adduct formation is not restricted to the oesophageal
mucosa. The papiilomas induced by NM2MBA show similarly
intensive labelling. Comparison with an adjacent section stained
with H&E reveals that only the heavily keratinized portions void
of viable nuclei lack 14C labelling. Similar results were obtained
on autoradiographs of other papiilomas in the same animal and
also when [l4C-methyl]NMAA was used as the chasing
carcinogen (not shown).
Immunohistochernistry offers the advantage of identifying cells
containing specific DNA adducts (19,20). In the present study,
we used a rabbit antiserum to C^-methyldeoxyguanosine (12).
When this technique was applied to oesophagi of rats chronically
exposed to NMBzA or NM2MBA in the drinking water, only
very few immunoreactive cells were detected in the basal layer
of the adjacent oesophageal mucosa, in regions with dysplasia
and in papiilomas (not shown). This is in agreement with earlier
observations (10) showing that this promutagenic base does not
accumulate in the target tissue. It appears that the high cell
turnover combined with moderately active DNA repair (21) leads
to a rapid loss of adduct from target organ DNA. We have
therefore chosen to use a single moderate to high chasing dose
in order to determine to what extent oesophageal papiilomas, i.e.
benign precursor lesions, maintain the capacity to enzymatically
convert methylalkylnitrosamines to their ultimate methylating
species. We found that during chronic exposure the oesophageal
mucosa undergoes thickening and hyperkeratosis and this is
paralleled by an increased number of methylated nuclei both in
the basal layer and in cells with incipient keratinization
(Figure 2A). Similarly, papiilomas exhibited a remarkable
potential for nitrosamine bioactivation. Again, immunoreactive
nuclei were located in the basal layer (Figure 2B) and in mucosal
cells migrating towards luminal surface (Figure 2C). Using an
antibody to BUdR, it was further established that nitrosamine-
induced papiilomas exhibit considerable proliferative potential:
following a single dose of BUdR, numerous S-phase nuclei were
detected throughout the papillomatous mucosa (Figure 2D). Our
results with oesophageal papiilomas are in agreement with recent
observations on the metabolism of the pancreatic carcinogen
azaserine by azaserine-induced foci and nodule cells of rat
pancreas (J.Bax and E.Scherer, unpublished results). They
contrast, however, with the observations in preneoplastic liver
foci, which consistendy lose the ability to metabolize hepato-
carcinogens (8,22), probably due to the increased expression of
P-glycoproteins (23,24) and the decreased expression of specific
cytochrome P450 isozymes (25).
Demonstration of the fully retained capacity for nitrosamine
bioactivation of oesophageal papiilomas is of considerable
significance for our understanding of the mechanism of malignant
transformation in this model system of target organ specificity.
Since oesophageal neoplasms in rats are usually induced by
chronic exposure, it must be assumed that the formation of
promutagenic DNA adducts and of somatic mutations derived
thereof continues throughout the early stages of initiation and
during clonal expansion of initiated cells to benign papiilomas.
Recent molecular genetic investigations have shown that NMBzA-
TaMe I. Treatment of animals used for the demonstration of nitrosamine bioactivation in oesophageal papiilomas
Carcinogen Exposure*
(p.p.m.)
Duration
(days)
Total dose
(mg)
Chasing
carcinogen
Chasing dose
(mg/kg)
NMBzAb
NMBzAb
NMBzAb
NM2MBA
NM2MBA
10.0
10.0
10.0
19.5
19.5
141
81
81
108
108
19.7
10.5
9.1
35.4
35.2
NMBzAc
NMBzAc
NMBzAc
[14C-methyl]NMBzAd
[l4C-methyl]NMAAc
15.0
15.0
15.0
4.9
9.1
"Refers to carcinogen concentration in the drinking water.
'to-administered with disulfiram (200 mg/kg food pellets).
cAdministered by i.p. injection. Chronic exposure to the carcinogen in the drinking water was discontinued immediately thereafter.
dAdministered by i.p. injection 17 days after cessation of chronic exposure to NM2MBA. Rats received a single s.c. dose of hydroxyurea (500 mg/kg) 30 min
prior to the carcinogen.
'Administered by i.p. injection 14 days after cessation of chronic exposure of NM2MBA. Rats received a single s.c. dose of hydroxyurea (500 mg/kg) 30 min
prior to the carcinogen.
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Fig. 1. Histopathology (H&E stain, left) and autoradiography (right) of a papilloma induced in a male F344 rat by chronic exposure to NM2MBA
(19.5 p.p.m. in the drinking water), following a chasing i.p. dose of [l4C-methyl]NMAA (9.1 mg/kg body wt; survival time 2 h). In order to suppress DNA
synthesis, the animal was given a single i.p. injection of hydroxyurea 30 min prior to nitrosamine application. X17.7.
Fig. 2. Imrnunocytochemical localization of C^-methyldeoxyguanosine in hyperkeratotic regions of the oesophageal mucosa (A) and in oesophageal papillomas
(B,C), induced by chronic exposure to NMBzA (10 p.p.m. in the drinking water), 6 h after a chasing dose of NMBzA (15 mg/kg body wt, i.p.). Localization
of proliferating cells (D) with a single dose of BUdR (20 mg/kg body wt; survival time, 2 h) using a monoclonal antibody to BUdR. Counterstained
with H&E ( A - Q or haematoxylin (D). X250.
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induced papillomas typically contain a GC to AT transition at
the second base in codon 12 of the H-ras gene (26). In mouse
skin it has been shown that the transition from papillomas to
carcinomas is most efficiently mediated by continuous
administration of an initiating agent, whereas tumour promotors,
although effective in inducing clonal expansion of initiated cells,
were ineffective in inducing further progression of the neoplasm
(27). Similarly, selective expansion of initiated acetylaminofluore-
resistant liver cells in female rats was rarely accompanied by
progression events. However, the subsequent application of the
directly alkylating carcinogen ethylnitrosourea, which does not
lead to the induction of tumors in this tissue when given as the
sole carcinogen (1), led to the formation of numerous neoplastic
nodules within foci of initiated cells (28). These findings underline
the importance of the capacity of preneoplastic and benign
precursor lesions to bioactivate non-direct-acting carcinogens
during the process of neoplastic progression.
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